Tesamorelin

Tesamorelin Peptide
Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analog developed for research involving endocrine modulation, growth hormone dynamics, and metabolic regulation. It binds to GHRH receptors in the anterior pituitary, stimulating controlled growth hormone secretion and downstream insulin-like growth factor-1 (IGF-1) signaling pathways. This mechanism makes it a valuable compound for studying lipid metabolism, body composition pathways, and hormonal regulation of adipose tissue in laboratory models. Research applications include investigations into visceral fat signaling, metabolic efficiency, and age-related changes in GH activity. Its receptor-specific action provides a structured framework for examining hypothalamic-pituitary interactions and growth hormone–mediated metabolic processes in controlled research settings.

Product Overview

Tesamorelin is a synthetic research peptide classified as a stabilized growth hormone–releasing hormone (GHRH) analog intended strictly for laboratory investigation. The Tesamorelin peptide features the molecular formula C221H366N72O67S and a molar mass of 5136 g/mol, reflecting its extended amino acid structure engineered for receptor specificity. This lyophilized Tesamorelin is supplied in sterile research vials containing 2 mg, 5 mg, 10 mg, or 20 mg of total active ingredient in high purity lyophilized form. Image alt text: lyophilized Tesamorelin peptide vial 10mg high purity research compound. Designed for stability under controlled storage conditions, Tesamorelin for research maintains integrity for up to 36 months when stored as recommended. This compound is for research and laboratory use only and is not for human or veterinary use.

Research Applications

Tesamorelin for research is utilized in experimental research settings focused on endocrine signaling and metabolic pathway analysis. In vitro studies frequently evaluate receptor-binding affinity and downstream intracellular responses following GHRH receptor activation. Pre-clinical models employ the Tesamorelin peptide to investigate growth hormone pulsatility and IGF-1–associated signaling cascades. Researchers also examine lipid metabolism markers and adipose tissue signaling responses under controlled laboratory conditions. Lyophilized Tesamorelin provides consistency for comparative laboratory investigation across endocrine-focused study designs. Its defined molecular profile supports reproducible experimentation in regulated research environments.

Reconstitution and Handling

Lyophilized Tesamorelin should be reconstituted using bacteriostatic water under strict aseptic technique within a controlled laboratory environment. The diluent should be introduced slowly along the inner vial wall to preserve peptide stability and minimize agitation. Avoid shaking the vial; instead, gently swirl until the solution becomes clear and fully dissolved. Proper handling of the Tesamorelin peptide ensures structural integrity for laboratory investigation. After reconstitution, the solution should be refrigerated at 2–8°C and protected from light exposure. All preparation procedures must follow institutional guidelines for research-use-only materials.

Mechanism of Action

Tesamorelin functions as a selective agonist of GHRH receptors located in the anterior pituitary in pre-clinical models. Upon receptor binding, the Tesamorelin peptide stimulates cyclic AMP production and regulated growth hormone secretion within experimental systems. This activation supports downstream IGF-1 signaling pathways that are frequently examined in metabolic and endocrine research. Tesamorelin for research demonstrates receptor-targeted activity with minimized off-target interaction in controlled settings. Investigators utilize lyophilized Tesamorelin to analyze feedback mechanisms between hypothalamic and pituitary pathways. These mechanistic properties make it suitable for laboratory investigation of growth hormone–mediated metabolic processes.

Research Dosage Guidelines

Research dosing ranges reported in published experimental literature vary depending on the specific in vitro studies or pre-clinical models employed. Concentration ranges are typically selected to evaluate receptor activation thresholds and hormonal response markers. In laboratory investigation settings, dosing parameters are adjusted according to study endpoints and analytical objectives. These research dosing ranges are provided for research reference only – not for human use. Tesamorelin for research should be quantified using calibrated laboratory equipment to ensure precision and reproducibility. Final protocol design remains the responsibility of qualified researchers operating under institutional compliance standards.

Potential Research Benefits

• Assessment of growth hormone receptor activation markers
• Evaluation of IGF-1 signaling pathway responses
• Observation of lipid metabolism indicators in tissue models
• Stability testing in simulated biological environments
• Analysis of endocrine feedback loop dynamics

Experimental Observations

Experimental observations of the Tesamorelin peptide in vitro studies demonstrate measurable receptor-mediated signaling activity. Laboratory findings indicate consistent structural stability of lyophilized Tesamorelin when stored under recommended conditions. Pre-clinical models report reproducible endocrine response patterns aligned with GHRH receptor stimulation. Tesamorelin for research has shown predictable receptor interaction potential in controlled assays. Investigators note reliable activation of downstream signaling cascades relevant to metabolic pathway analysis. These findings reinforce its applicability in structured endocrine laboratory investigation.

Research Considerations

Researchers utilizing the Tesamorelin peptide should ensure precise environmental controls to prevent degradation or contamination. Verification of peptide identity and batch consistency is recommended for advanced analytical studies. Lyophilized Tesamorelin must be handled exclusively by trained laboratory personnel familiar with peptide research protocols. Appropriate documentation and regulatory approvals should be secured prior to experimental use. Tesamorelin for research should remain confined to designated laboratory facilities at all times. Careful procedural planning supports reproducibility and data integrity in experimental research settings.

Safety Notice

Tesamorelin is supplied strictly for laboratory research purposes only and is not intended for human or veterinary use. Standard laboratory protective equipment should be worn during handling and preparation. Avoid inhalation, ingestion, or direct contact with skin and eyes. Dispose of all materials in accordance with institutional biosafety regulations. Researchers are responsible for compliance with applicable local, national, and international guidelines governing peptide research.

Disclaimer: This product is intended strictly for laboratory research purposes only and is not for human or veterinary use. The information provided is for educational and scientific reference and should not be interpreted as medical advice or as a recommendation for any form of administration. Researchers should follow all applicable regulations and institutional guidelines when handling this material.

Storage Information

For long-term preservation, Tesamorelin peptide should be stored at −20°C to maintain molecular stability. Short-term storage may be maintained at 2–8°C under refrigeration. Lyophilized Tesamorelin should be protected from light to prevent degradation. Avoid repeated freeze-thaw cycles, as they may compromise structural integrity and experimental consistency. When stored according to recommended guidelines, the shelf life is 36 months. Proper storage ensures Tesamorelin for research maintains quality for extended laboratory use.

Purity & Quality

All Tesamorelin vials stocked by MedsBase are supplied at 99%+ HPLC purity in lyophilized form. A certificate of analysis (COA) is available on request — message our support team after placing your order and we will forward the batch-specific COA for the vials you received.

Συχνές Ερωτήσεις

What is the regulatory status of Tesamorelin?

Tesamorelin is not approved for human therapeutic use in the United States, European Union, United Kingdom, Canada, or Australia. It is sold for research-use applications only. Some peptides in this class have been used in early-phase clinical trials but no major regulator has issued a marketing authorization for the indications discussed in the popular literature.

How is Tesamorelin reconstituted?

Lyophilized peptides are typically reconstituted with bacteriostatic water or sterile water for injection (BWFI / SWFI) at a concentration appropriate for the planned dose. Add the diluent slowly down the inside wall of the vial — do not inject the stream directly into the powder cake or shake vigorously, as both denature the peptide. Swirl gently until fully dissolved. Reconstituted peptides are typically stored refrigerated at 2–8°C.

How should Tesamorelin be stored?

Lyophilized vials are stable for extended periods when stored at −20°C or refrigerated at 2–8°C, away from direct light. After reconstitution, most peptides are stable for 14–30 days refrigerated, depending on the buffer and the specific peptide. Always read the certificate of analysis included with the vial for the supplier’s recommended storage and stability data.

What does the published research show?

The published literature on Tesamorelin is summarized in our linked research guide. We separate preclinical (rodent / cell-culture) data, where it is consistent and reproducible, from clinical-trial data, where evidence is typically thinner. We also flag where popular online claims outrun the published record.

Is Tesamorelin legal to order internationally?

Research peptides occupy an ambiguous regulatory space. Importation rules vary by country and have changed in several jurisdictions over the past few years. It is the buyer’s responsibility to confirm import legality in their destination country before ordering. MedsBase ships peptides worldwide via our dedicated peptide courier; orders that contravene the destination country’s import rules may be detained at customs.

What is the half-life of Tesamorelin?

Tesamorelin has a plasma half-life of approximately 26–38 minutes in clinical studies of the approved Egrifta formulation — longer than native GHRH(1-44) due to the trans-3-hexenoic acid modification that protects against DPP-IV cleavage. Most research protocols use once-daily subcutaneous administration.

How does Tesamorelin differ from Sermorelin?

Tesamorelin is the full-length GHRH(1-44) analog with a fatty acid modification that extends its half-life, whereas Sermorelin is the truncated GHRH(1-29) fragment without modification. Tesamorelin has FDA approval for HIV-associated lipodystrophy, giving it a more developed clinical dataset. Both stimulate pituitary GH release, but Tesamorelin has a modestly longer action window.

Can I order Tesamorelin alongside other peptides?

Yes. Peptide orders are bundled and ship together via our peptide-only courier service. Lyophilized vials are temperature-stable for the duration of standard international transit. See our peptide category page for the full stocked range and the “Best Peptides for Recovery” comparison guide for stacking considerations from the published literature.

If your protocol pairs tesamorelin’s GHRH-driven GH release with localised tissue-repair peptides, our Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg + bacteriostatic water) covers the angiogenesis + cytoskeletal-repair layer in one parcel at the $0 peptide-shipping rate.

Other Peptides for Recovery and Performance Research

• BPC-157 — Body Protection Compound — tendon, ligament, gut recovery research
• TB-500 — Thymosin Beta-4 fragment — soft tissue and vascular recovery research
• Ipamorelin — Selective ghrelin agonist — clean GH pulse without cortisol/prolactin
• CJC-1295 with DAC — GHRH analog with extended half-life
• GHK-Cu — Copper peptide — skin and connective tissue regeneration research

Further Reading

📦 Κάθε παραγγελία καλύπτεται από την Πολιτική Εγγύησης Επαναποστολής — εάν το δέμα σας δεν φτάσει εντός 20 εργάσιμων ημερών, το επαναποστέλλουμε.

More options in Peptides

Ταξινομημένα σύμφωνα με τον όγκο παραγγελιών στο MedsBase — τι επιλέγουν άλλοι πελάτες σε αυτήν την κατηγορία.

BPC-157

US$115.00 – US$705.00Εύρος τιμών: από US$115.00 έως US$705.00

Retatrutide

US$310.00 – US$6,515.00Εύρος τιμών: από US$310.00 έως US$6,515.00

BAC Water (Bacteriostatic Water)

US$50.00 – US$150.00Εύρος τιμών: από US$50.00 έως US$150.00

NAD⁺

US$210.00 – US$1,975.00Εύρος τιμών: από US$210.00 έως US$1,975.00